WEBULL
News
NVRO
5.84
0.00%
0.00
*News On Nevro Corp. (NVRO) Now Under GMED
Dow Jones · 04/02 21:09
Weekly Report: what happened at NVRO last week (0324-0328)?
Weekly Report · 03/31 09:25
Catalyst Watch: Tariff repercussions, Tesla deliveries, the jobs report, and Microsoft turns 50
Seeking Alpha · 03/28 19:00
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?
NASDAQ · 03/28 11:28
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
TipRanks · 03/25 10:10
Weekly Report: what happened at NVRO last week (0317-0321)?
Weekly Report · 03/24 09:22
NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO
Barchart · 03/21 10:30
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
NASDAQ · 03/19 15:32
Weekly Report: what happened at NVRO last week (0310-0314)?
Weekly Report · 03/17 09:24
Weekly Report: what happened at NVRO last week (0303-0307)?
Weekly Report · 03/10 09:25
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Wave Life Sciences (WVE) and Nevro Corp (NVRO)
TipRanks · 03/05 11:42
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
Barchart · 03/05 11:40
Nevro Corp. Reports 2024 Financial Results Amid Acquisition News
TipRanks · 03/05 03:54
NEVRO CORP. FORM 10-K
Press release · 03/04 23:14
*Nevro Not Issuing Guidance Due to Pending Acquisition by Globus Medical >NVRO
Dow Jones · 03/04 21:27
Nevro is not issuing FY25 guidance
TipRanks · 03/04 21:21
The future of U.S. medical devices companies amid tariff impositions
Seeking Alpha · 03/03 19:56
Weekly Report: what happened at NVRO last week (0224-0228)?
Weekly Report · 03/03 09:25
NEVRO Earnings Preview: Recent $NVRO Insider Trading, Hedge Fund Activity, and More
NASDAQ · 03/02 21:06
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Nevro Corp (NVRO)
TipRanks · 02/24 11:10
More
Webull provides a variety of real-time NVRO stock news. You can receive the latest news about Nevro Corp through multiple platforms. This information may help you make smarter investment decisions.
About NVRO
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.